Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Sell
6,402
-4,313
-40% -$225K ﹤0.01% 1116
2026
Q1
$496K Buy
10,715
+6,212
+138% +$327K ﹤0.01% 844
2025
Q4
$237K Sell
4,503
-1,615
-26% -$81.8K ﹤0.01% 941
2025
Q3
$333K Buy
+6,118
New +$328K ﹤0.01% 739
2025
Q1
Sell
-5,308
Closed -$213K 2172
2024
Q4
$213K Buy
+5,308
New +$176K ﹤0.01% 1337
2023
Q1
Sell
-1,000
Closed -$12.3K 1868
2022
Q4
$12.3K Hold
1,000
﹤0.01% 1294
2022
Q3
$8K Hold
1,000
﹤0.01% 1403
2022
Q2
$12K Hold
1,000
﹤0.01% 1529
2022
Q1
$17K Buy
+1,000
New +$27.2K ﹤0.01% 1499
2020
Q4
Sell
-6,086
Closed -$192K 1118
2020
Q3
$192K Buy
+6,086
New +$234K 0.01% 611

Other funds holding VEON

Centiva Capital's VEON Position: Q2 2026 in Review

Centiva Capital reduced its VEON (VEON) stake by 40% in Q2 2026, selling an estimated $225K and leaving 6,402 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

Centiva Capital first reported a position in VEON in Q3 2020 and has held it in 10 quarters since. The position peaked at $496K in Q1 2026. 111 funds tracked by Wall St. Rank hold VEON as of Q2 2026.

  • Centiva Capital held 6,402 shares of VEON worth $334K as of Q2 2026.
  • Centiva Capital sold 4,313 VEON shares in Q2 2026, an estimated $225K.
  • VEON made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1116 holding.
  • Centiva Capital first reported a position in VEON in Q3 2020 and has held it in 10 quarters since.
  • Centiva Capital's VEON position peaked at $496K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held VEON as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.